Featured Abstracts
Review key findings and research highlights presented at major industry conferences and events.
Featured Content
AAPM
NTCP Modeling of Dose to Bladder and Urethra with Urinary Symptoms Following Prostate Cyberknife SBRT.
AAPM
Optimized Dosimetric Planning for Trigeminal Neuralgia Using CyberKnife S7 Precision TPS with Volo Optimizer
AAPM
Precise Measurement of Leaf Open Time in TomoTherapy Using Advanced Plastic Scintillators
Featured Case Studies
Transition to the Radixact® System for Pediatric Total Body Irradiation (TBI) Treatment
A 6-year-old boy presented with a high white blood cell count and a mediastinal mass. He was diagnosed with high-risk T-cell acute lymphoblastic leukemia (ALL) and treated in the ALLTogether1 trial1. During induction therapy with regimen B, the patient continued to have high levels of minimal residual disease (MRD). Subsequently,
Precision and Innovation: Insights on a robust radiation oncology practice from a long-term CyberKnife® System user
According to the World Health Organization, in 2050 more than 35 million new cancer cases will be diagnosed, a 77 percent increase from the estimated 20 million cases in 20221. Men are anticipated to be the hardest hit, with a study in the journal Cancer finding that global cancer cases
Deep Inspiration Breath Hold Using VitalHold™ on the Radixact® System
A 45-year-old female patient was diagnosed with pT2N1M0 invasive ductal carcinoma of the left breast. The patient underwent breast conservation surgery with axillary dissection, followed by chemotherapy and radiation therapy. Radiation therapy was delivered by the Radixact® System, the latest generation of the TomoTherapy® Platform with surface guided radiotherapy (SGRT)
1228: Preliminary Results of a CyberKnife SBRT for Extracranial Sites From a Tertiary Institute
Bhooshan Zade et al. | ESTRO | 2025
3605: Higher Disease-free Survival Observed for Complete Response After SBRT in Oligometastatic Gynecologic Tumors
Gaia Parma et al. | ESTRO | 2025
4246: Consecutive Radiosurgery for Multiple Brain Metastases with CyberKnife Robotic Radiosurgery Unit: Outcomes and Predictive Factors at a Hospital Center
Ignacio María Gómez Paloma et al. | ESTRO | 2025
4197: The Efficacy of CyberKnife® Stereotactic Radiation Therapy in Re-irradiation of Recurrent Glioblastoma.
Hanna Grzbiela et al. | ESTRO | 2025
4071: Hypofractionated Radiosurgery for Functioning and Non-functioning Pituitary Adenomas After Surgery: Our Working Experience with CyberKnife Unit
Julen Azcona Martin et al. | ESTRO | 2025
2604: Stereotactic Radiosurgery of Brain Metastases from Cancers that Rarely Metastasize to the Central Nervous System
Senay Mutaf et al. | ESTRO | 2025
Novel Therapeutic Approach to a Solitary Vertebral and Para-Vertebral Body Metastasis: Long-Term Follow-Up
Angela Zhu et al. | RSS | 2025
Long-Term Outcomes of Vestibular Schwannoma Treated with Stereotactic Radiosurgery: A Retrospective Study from a Single Institution
David J. Park et al. | RSS | 2025
Two Years’ Experience with Stereotactic Body Radiotherapy for Localized Prostate Cancer Using the CyberKnife System
Shaima Shoeir et al. | RSS | 2025
Enhancing Patient-Specific QA in IGRT: Utilizing the OCTAVIUS Detector 1600 SRS with CyberKnife
Ryan Oglesby et al. | RSS | 2025
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
David J. Park et al. | RSS | 2025
Efficacy and Safety of CyberKnife Stereotactic Radiosurgery for Occipital Condyle Metastasis
David J. Park et al. | RSS | 2025
Frameless Radiosurgery is a Safe and Effective Treatment for Medically-Refractory Trigeminal Neuralgia in Elderly Patients
Pantaleo Romanelli et al. | RSS | 2025
